Research identifies nine potential new COVID-19 treatments IANS Apr 4, 2021 Three already have FDA approval — the transplant-rejection drug cyclosporine, the cancer drug dacomitinib, and the antibiotic…
Intravacc gets US NIAID contract to develop enterovirus D68 vaccine EP News Bureau Sep 8, 2020 EV D68 is a respiratory virus that can cause childhood paralysis, acute flaccid myelitis